{"id":24053,"date":"2022-05-13T14:49:09","date_gmt":"2022-05-13T13:49:09","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=24053"},"modified":"2022-05-13T14:49:12","modified_gmt":"2022-05-13T13:49:12","slug":"industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/","title":{"rendered":"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia"},"content":{"rendered":"\n

Article published on University of South Australia<\/a> website on May 06, 2022<\/p>\n\n\n\n

A new partnership to improve the resilience and profitability of Australia\u2019s food and agribusiness industries has been kickstarted with a $34.5 million Federal Government grant announced today.<\/p>\n\n\n\n

The Cooperative Research Centre for Solving Antimicrobial Resistance in Agribusiness, Food, and Environments (CRC SAAFE<\/a>), involving 70 partners contributing an additional $115 million cash and in-kind support, is led by UniSA environmental scientist\u00a0Professor Erica Donner<\/a>.<\/p>\n\n\n\n

Over the next decade the $149 million project will tackle resistance to essential antibiotics, antifungals and antivirals that, if not addressed, could wipe up to $283 billion from the Australian economy by 2050.<\/p>\n\n\n\n

Antimicrobials such as antibiotics, antifungals and antivirals are essential for managing disease in humans, animals and plants, however, their widespread use has led to microbes becoming resistant to them, rendering them ineffective, a phenomenon called antimicrobial resistance (AMR).<\/p>\n\n\n\n

Prof Donner, Research Leader in the University of South Australia\u2019s\u00a0Future Industries Institute<\/a>, and CEO of CRC SAAFE, says AMR needs to be tackled at its source, where it emerges and spreads between farms, in feed and food production systems, and in waste processing.<\/p>\n\n\n\n

\u201cAntimicrobials are used in so many ways. They are used to treat our livestock, our crops, and ourselves. They end up being flushed down toilets, sprayed in organic fertiliser, carried through water supplies, produce and stock feed. We need to do everything we can to stop the spread of resistance,\u201d Prof Donner says.<\/p>\n\n\n\n

Partners from the water, organic waste, aquaculture, horticulture, viticulture, animal feed and livestock sectors will work together to develop shared solutions to monitor, manage and mitigate the spread of AMR .<\/p>\n\n\n\n

New technologies deployed will include IoT sensors, genome sequencing, artificial intelligence and  advanced analytics. CRC SAAFE partners will develop solutions such as vaccines, water treatment technologies and  new animal feeds and supplements.<\/p>\n\n\n\n

AMR can be spread through water, food, waste, animals and humans. Antimicrobial-resistant microbes can also cross-national borders, posing a biosecurity risk and potentially threatening valuable export markets.<\/p>\n\n\n\n

Approximately five million people die each year from AMR-associated infections and that figure is expected to increase exponentially unless urgent action is taken.<\/p>\n\n\n\n

The World Health Organisation has declared that AMR is one of the top 10 global public health threats facing humanity.<\/p>\n\n\n\n

\u201cAntimicrobial resistance makes our food supply less safe. Internationally, there are many cases of multidrug resistant bacterial strains causing serious disease being spread via food. CRC SAAFE will help Australian industries stay on top of this risk, ensuring we remain a top producer of premium food and beverage products,\u201d Prof Donner says.<\/p>\n\n\n\n

AMR is also a significant problem in animal production, the wine sector and agricultural industries, costing producers hundreds of millions of dollars a year in lost production and failed crops.<\/p>\n\n\n\n

The World Bank has valued antimicrobial effectiveness at US$20-55 trillion, advising that action to mitigate antimicrobial resistance is one of the highest-yield development investments available to countries today.<\/p>\n\n\n\n

\u201cUniSA is thrilled to work with its CRC SAAFE partners over the next decade to advance this critical work. By co-developing technologies and solutions to mitigate AMR, we will deliver benefits for all Australians,\u201d Prof Donner says.<\/p>\n\n\n\n

CRC SAAFE Chair, Karlene Maywald, says Australian industries need to be able to develop the knowledge to first manage the risks of AMR and then develop the technologies and the tools to mitigate them.<\/p>\n\n\n\n

\u201cCRC SAAFE will ensure that Australia is at the leading edge of research to support industry to tackle the threat of AMR,\u201d Ms Maywald says.<\/p>\n\n\n\n

The participating organisations are listed here:\u00a0https:\/\/www.crcsaafe.com.au\/partners<\/a><\/p>\n\n\n\n


Contact for interview:\u00a0<\/strong>\u00a0

Professor Erica Donner, CEO of CRC SAAFE\u00a0M:<\/strong>\u00a00414 951 183\u00a0E:\u00a0<\/strong>erica.donner@unisa.edu.au<\/a>
Professor Marnie Hughes-Warrington, UniSA Deputy Vice Chancellor: Research and Enterprise
E:<\/strong>\u00a0marnie.hughes-warrington@unisa.edu.au<\/a>

Media contact:<\/strong>\u00a0Candy Gibson\u00a0M:<\/strong>\u00a00434 605 142\u00a0E:<\/strong>\u00a0candy.gibson@unisa.edu.au<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Article published on University of South Australia website on May 06, 2022 A new partnership to improve the resilience and profitability of Australia\u2019s food and agribusiness industries has been kickstarted with a $34.5 million Federal Government grant announced today. The Cooperative Research Centre for Solving Antimicrobial Resistance in Agribusiness, Food, and Environments (CRC SAAFE), involving […]<\/p>\n","protected":false},"author":139,"featured_media":24059,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"\nIndustry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-13T13:49:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-13T13:49:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"653\" \/>\n\t<meta property=\"og:image:height\" content=\"529\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia\",\"datePublished\":\"2022-05-13T13:49:09+00:00\",\"dateModified\":\"2022-05-13T13:49:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\"},\"wordCount\":646,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\",\"name\":\"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg\",\"datePublished\":\"2022-05-13T13:49:09+00:00\",\"dateModified\":\"2022-05-13T13:49:12+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg\",\"width\":653,\"height\":529,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/","og_locale":"en_GB","og_type":"article","og_title":"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2022-05-13T13:49:09+00:00","article_modified_time":"2022-05-13T13:49:12+00:00","og_image":[{"width":653,"height":529,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia","datePublished":"2022-05-13T13:49:09+00:00","dateModified":"2022-05-13T13:49:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/"},"wordCount":646,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/","name":"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg","datePublished":"2022-05-13T13:49:09+00:00","dateModified":"2022-05-13T13:49:12+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/05\/Australia.jpg","width":653,"height":529,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/industry-and-research-join-forces-to-tackle-283-billion-antimicrobial-resistance-threat-to-australia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Industry and research join forces to tackle $283 billion antimicrobial resistance threat to Australia"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-23 17:05:51","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/24053"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=24053"}],"version-history":[{"count":4,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/24053\/revisions"}],"predecessor-version":[{"id":24065,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/24053\/revisions\/24065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/24059"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=24053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=24053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=24053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}